Followers | 191 |
Posts | 6887 |
Boards Moderated | 1 |
Alias Born | 10/05/2010 |
Monday, August 10, 2020 10:40:09 PM
The Q2 report was unsurprising. The company has roughly $960k of Cash and Equivalents, Receivables and Deposits, while their Total Debt is roughly $393k. $30k of their debt is Stock Payable, but there are no other dilutive instruments, convertible notes etc. Revenues for the quarter were $550k vs $731k in the same quarter last year. Gross Margins were 43% vs 68% last year, this is due to a significant change in the mix of Consulting Revenue vs Product Equipment Revenue. Net Loss was $102k vs Net Profits of $172k last year. The Outstanding Shares increased by 5% to 54.2m. Of that O/S, Officers and Directors own nearly 24m shares, the Float is roughly 31m shares.
The Year over Year comparison is a tough measure, considering the huge difference in the economy etc. between the two. A sequential comparison, Q1 vs Q2, shows actual improvement. Revenues improved from $440k to $550k, while the Net Loss went from $177k to $102k.
I don’t often look at valuations for OTC stocks, but AMMJ has an interesting anomaly. The current Market Capitalization of the company (Outstanding Shares x Share price) is $6m; what the whole company is valued at. However, they have an available loan facility of up to $7.5m. So, they are currently valued at less than the money they can borrow, I find that somewhat comical.
Using a three-year weekly chart, the Long-term downtrend is fairly obvious, however a support range between .085 and .10 has been established this year. It also temporarily broke the 50wma for the first time in three years. The RSI is a bit low at 42, and there are signs of a 20/50wma Golden Cross setting up, but it has a bit to go. The two Moving Averages will provide resistance from .14 - .16, with key resistance after that being .20 - .22. The MACD has been divergent from the share price for two years, and recently touched the Center-line for the first time in more than that; I see this as very positive. The drop in the OBV is less than the share price would indicate, I see this as a positive as well.
http://schrts.co/wgYbFDyk
Switching to a six-month daily chart, the RSI is fairly low at 41. There was a 50/200dma Golden Cross in June which is about to turn to a Death Cross, due to the recent price declines. The Resistance around .14 is fairly obvious. Support at .10 has been established, however there has not been a significant volume test of it. The MACD has had a Bullish Signal Line Crossover, but remains below the Center-line. The OBV seems appropriate for the price action.
http://schrts.co/hgMhIhed
Some of the recent downward pressure on the price has been caused by a large shareholder, Mr. Hollister, making what appear to be planned sales, he does this every 3-4 month for roughly 500k shares. The last of his sales were a month ago, so I expect him to be done until Oct – Nov. Also, in June the company tapped some of its credit line and issued 250k shares to White Lion Capital. There are no sales restrictions that I am aware of, so it is possible they sold them into the market as well.
See Form 4's for Mr. Hollister's sales,
https://www.otcmarkets.com/stock/AMMJ/disclosure
AMMJ has some work to do, but they are financially strong and the share dilution is minimal; something most companies in the industry can only dream of.
All the best,
Knife
Recent AMMJ News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 05:23:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:27:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 06:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:42:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:08:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 06:36:07 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/21/2023 04:33:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 03:40:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:17:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:07:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:54:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:46:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:37:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/24/2023 05:51:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:02:42 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM